Document Detail

1:7 ratio in the distribution of adw and ayw subtypes in a population of HBs Ag-positive hepatitis patients in northern Italy
MedLine Citation:
PMID:  1125109     Owner:  NLM     Status:  MEDLINE    
The subtypes of HBsAg have been determined in 41 cases of acute type B hepatitis by counterelectrophoresis (CEP) using mono-specific D (anti-d), Y (anti-y), W (anti-w) and R (anti-r) antisera following Dr. Holland's technique. In 36 cases (87.8 percent) the subtype was ayw and in 5 (12.3 per cent) adw. Neither r subtypes nor simultaneous presence in the same patient of both d and y subtypes were detected. The subtype distribution in Itayl is closely related to the observed distribution of d/y subtypes in the Mediterranean countries, except for Spain, showing a pattern similar to that of Central and Northern Europe countries.
G Gerna
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Bollettino dell'Istituto sieroterapico milanese     Volume:  54     ISSN:  0021-2547     ISO Abbreviation:  Boll Ist Sieroter Milan     Publication Date:  1975  
Date Detail:
Created Date:  1975-08-08     Completed Date:  1975-08-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  17720040R     Medline TA:  Boll Ist Sieroter Milan     Country:  ITALY    
Other Details:
Languages:  ita     Pagination:  19-23     Citation Subset:  IM    
Vernacular Title:
Rapporto 1:7 nella distribuzione dei sottotipi adw e ayw in una popolazione di epatiti HBsAg-positive dell'Italia settentrionale
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Group Antigens*
Hepatitis B / epidemiology*
Hepatitis B Antigens* / analysis
Reg. No./Substance:
0/Blood Group Antigens; 0/Hepatitis B Antigens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nonvirionic inhibitor of DNA synthesis in human embryo fibroblast cell cultures infected with rubell...
Next Document:  The antigenic structure of Toxoplasma gondii. III. Behavior of human sera as compared with purified...